uniQure Company

Developing therapy for genetic diseases of the central nervous system (CNS) and liver
Technology: Others
Industry: Gene Therapy
Headquarters: Amsterdam, The Netherlands
Founded Date: 2012
Funding Status: IPO
Total Funding: $274.5K
Estimated Revenue: $1M to $10M
Last Funding Type: Seed

Visit Website
info@uniQure.com
https://twitter.com/uniQure_NV
Register and Claim Ownership